drug
VARENICLINE TARTRATE
Marketedupdated 3mo agoby Oyster Point Pharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(3)
Trials studying VARENICLINE TARTRATE
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 19, 2035
~9.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (10)
- Oct 19, 2035formulationUS 10456396
- Oct 19, 2035method-of-use (U-1900)US 11224598
- Oct 19, 2035method-of-use (U-1900)US 11903941
- Oct 19, 2035formulationUS 11903942
- Oct 19, 2035method-of-use (U-1900)US 11903943
- Oct 19, 2035method-of-use (U-1900)US 11911380
- Oct 19, 2035method-of-use (U-1900)US 9504644
- Oct 19, 2035formulationUS 9504645
- Oct 19, 2035method-of-use (U-1900)US 9532944
- Oct 19, 2035method-of-use (U-1900)US 9597284
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that